Pfizer urged to wait for November to seek vaccine authorization
Pfizer Inc. should wait until at least late November before seeking FDA authorization of its COVID-19 vaccine to meet rigorous safety standards, more than 60 leading researchers an…
Pfizer Inc. should wait until at least late November before seeking FDA authorization of its COVID-19 vaccine to meet rigorous safety standards, more than 60 leading researchers an…